Double Orifice Mitral Valve Follow-up

Updated: Mar 19, 2014
  • Author: Georgios A Hartas, MD, FACC, FSCAI, FAAP; Chief Editor: Stuart Berger, MD  more...
  • Print
Follow-up

Further Outpatient Care

Monitor medication for compliance, dose requirements, and adverse effects.

Periodically check for electrolyte disturbances.

Provide follow-up care for prompt detection and treatment of intercurrent infections, arrhythmia, and other complications.

Next:

Further Inpatient Care

The following are indicated in patients with double orifice mitral valve (DOMV):

  • Hemodynamic study by cardiac catheterization and angiography

  • Surgical treatment

Previous
Next:

Inpatient & Outpatient Medications

Medications for double orifice mitral valve include diuretics, digoxin, potassium chloride, and vasodilators.

Previous
Next:

Transfer

Transfer to a tertiary cardiac facility may be required for further diagnostic evaluation and surgical treatment.

Previous
Next:

Deterrence/Prevention

Symptomatic patients with double orifice mitral valve should avoid sports and other strenuous activity that could aggravate their pulmonary congestion and congestive heart failure (CHF).

Previous
Next:

Complications

Possible complications are mitral regurgitation, mitral stenosis, pulmonary edema, recurrent respiratory infection, atrial fibrillation and other atrial arrhythmias, infective endocarditis, left atrial thrombus, and pulmonary arterial hypertension.

Previous
Next:

Prognosis

Encourage activity restrictions on symptomatic patients. Advise the patient/parents concerning the need for periodic medical review. Counsel the patient/parents about the need for regular anticoagulant therapy with warfarin (Coumadin) in those who undergo valve replacement.

Previous
Next:

Patient Education

Impose activity restrictions on symptomatic patients.

Advise the patient concerning the need for periodic medical review.

Inform the patient regarding prophylaxis for infective endocarditis and prompt attention to all infections.

Counsel the patient about the need for regular anticoagulant therapy with warfarin (Coumadin) in those who undergo valve replacement.

Previous